About CinARC

The Cincinnati Addiction Research Center (CinARC) was created in 1995 and commenced work in October of that year as the Cincinnati NIDA VA/UC Medication Development Research Unit (MDRU). The staff of CinARC includes experienced investigators from the University of Cincinnati and the Cincinnati Veterans Administration Medical Center, as well as seasoned therapists, research assistants, nurses, and quality assurance, regulatory, administrative, and computer-support personnel.

Since 1995, CinARC, led by Dr. Eugene Somoza, has gained a reputation for excellence in the conduct of clinical trials, as evidenced by the award of a NIDA Clinical Trials Operations (CTO) contract in 1999 and a NIDA Medication Development for Stimulants (MDS-II) contract in 2007. Through the MDRU, CTO, and MDS-II mechanisms, the CinARC team has completed 14 clinical trials at the Cincinnati and Dayton, OH, VA hospitals, the majority of which have been pharmacological trials for cocaine dependence. CinARC has also completed numerous pharmaceutical company-sponsored substance-abuse clinical trials.

At the national level, CinARC established the Ohio Valley Node (OVN) of NIDA’s Clinical Trials Network (CTN) in 2000 and acts as its “Regional Research and Training Center.” Twenty three community treatment programs throughout the Midwest and in Kentucky, Tennessee, and West Virginia are also part of the OVN. To date the OVN has participated in twenty CTN clinical trials and other studies.

slideshow.